|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 9 3059-3066, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
AL Jenkins, GL Howells, E Scott, BF Le Bonniec, MA Curtis and SR Stone
Department of Haematology, University of Cambridge, UK.
Human alpha-thrombin was a chemoattractant for human neutrophils yielding a maximal response of similar magnitude to that observed with formyl-Met-Leu-Phe. The observed chemotaxis was not due to stimulation of the proteolytically activated thrombin receptor since: (1) this receptor was not detected by flow cytometry; (2) the inactive thrombin mutant Ser195-->Ala elicited a chemotactic response indistinguishable from that caused by wild-type thrombin; (3) antibodies to the cleavage site of the proteolytically activated receptor did not affect thrombin-induced chemotaxis; (4) a thrombin receptor activating peptide (TRAP) failed to stimulate chemotaxis. These data indicate the existence of a thrombin receptor for neutrophil chemotaxis which is not activated by proteolysis. In addition, although wild-type and ser195-->Ala thrombin did not cause an increase in intracellular Ca2+, a Ca2+ response to TRAP was observed with neutrophils from some donors. The TRAP-induced increase in Ca2+ was reproducible, dose dependent and specific. The use of alanine-substituted peptides demonstrated that the Ca2+ response was due to TRAP stimulation of a receptor other than the proteolytically activated thrombin receptor. Thus, it is necessary to re-evaluate the assumption made in previous studies that responses to TRAP are mediated by the proteolytically activated thrombin receptor.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  J. T. Ryaby, M. R. Sheller, B. P. Levine, D. G. Bramlet, A. L. Ladd, and D. H. Carney Thrombin Peptide TP508 Stimulates Cellular Events Leading to Angiogenesis, Revascularization, and Repair of Dermal and Musculoskeletal Tissues J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 132 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Song, C. N. Pagel, T. M. Campbell, R. N. Pike, and E. J. Mackie The Role of Protease-Activated Receptor-1 in Bone Healing Am. J. Pathol., March 1, 2005; 166(3): 857 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yoshida, S. G. Elner, Z.-M. Bian, S. L. Kunkel, N. W. Lukacs, and V. M. Elner Thrombin Regulates Chemokine Induction during Human Retinal Pigment Epithelial Cell/Monocyte Interaction Am. J. Pathol., September 1, 2001; 159(3): 1171 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ross, B. Essary, B. A. de la Houssaye, Z. Pan, K. Mikule, O. Mubarak, and K. H. Pfenninger Thrombin Causes Pseudopod Detachment via a Pathway Involving Cytosolic Phospholipase A2 and 12/15- Lipoxygenase Products Cell Growth Differ., January 1, 2000; 11(1): 19 - 30. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Howells, M. Macey, C Chinni, L Hou, M. Fox, P Harriott, and S. Stone Proteinase-activated receptor-2: expression by human neutrophils J. Cell Sci., January 4, 1997; 110(7): 881 - 887. [Abstract] [PDF]
|
|
|
|
 |
|
 H. S. Suidan, S. P. Niclou, J. Dreessen, N. Beltraminelli, and D. Monard The Thrombin Receptor Is Present in Myoblasts and Its Expression Is Repressed upon Fusion J. Biol. Chem., November 15, 1996; 271(46): 29162 - 29169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
BrianD. Blackhart, K. Emilsson, D. Nguyen, W. Teng, ArnoldJ. Martelli, S. Nystedt, J. Sundelin, and RobertM. Scarborough Ligand Cross-reactivity within the Protease-activated Receptor Family J. Biol. Chem., July 12, 1996; 271(28): 16466 - 16471. [Abstract] [Full Text] [PDF]
|
|
